Advanced Proteome Therapeutics Corporation (TSXV:APC) announced a non-brokered private placement of 6,097,561 units at a price of CAD 0.205 per unit for gross proceeds of CAD 1,250,000.005 on March 1, 2021. Each unit consists of one common share and one transferable common share purchase warrant, with each whole warrant exercisable for a period of 12 months from the date of closing at a price of CAD 0.27 per share. Finder’s fees may be payable in accordance with the policies of the TSX Venture Exchange. All securities issued in connection with the private placement are subject to a 4-month hold period in Canada. The transaction is subject to the approval of the TSX Venture Exchange. Closing of the transaction is expected to occur on or before March 19, 2021.